ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation

Stem Cell Reports

Volumn 7, Issue 4, 2016, Pages 693-706

  Zimmermann, Tina ^a   Remmers, Floortje ^a   Lutz, Beat ^a   Leschik, Julia ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

brain derived neurotrophic factor; embryonic stem cells; Huntington's disease; striatal differentiation

Indexed keywords

ASPARTOACYLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; FORKHEAD TRANSCRIPTION FACTOR; QUINOLINIC ACID; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; BODY WEIGHT; CATWALK GAIT ANALYSIS TEST; CELL FATE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; GENETIC MODEL; GRIP STRENGTH; HINDLIMB; HUNTINGTON CHOREA; MOTOR PERFORMANCE; MOUSE; MOUSE MODEL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; ROTAROD TEST; STEM CELL TRANSPLANTATION; SUBVENTRICULAR ZONE; TRANSGENIC MOUSE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; GLIA; LOCOMOTION; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; REPORTER GENE;

ANIMALS; BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL SURVIVAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENES, REPORTER; HUNTINGTON DISEASE; LOCOMOTION; MICE; NEURAL STEM CELLS; NEUROGLIA; NEURONS; STEM CELL TRANSPLANTATION;

EID: 84992187922     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2016.08.018     Document Type: Article

References (39)

1. Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., Perrier, A.L., Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 105 (2008), 16707–16712.
2. Bachoud-Levi, A.C., Gaura, V., Brugieres, P., Lefaucheur, J.P., Boisse, M.F., Maison, P., Baudic, S., Ribeiro, M.J., Bourdet, C., Remy, P., et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 5 (2006), 303–309.
3. Behrstock, S., Ebert, A.D., Klein, S., Schmitt, M., Moore, J.M., Svendsen, C.N., Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant. 12 (2008), 753–762.
4. Bernreuther, C., Dihne, M., Johann, V., Schiefer, J., Cui, Y., Hargus, G., Schmid, J.S., Xu, J., Kosinski, C.M., Schachner, M., Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum. J. Neurosci. 26 (2006), 11532–11539.
5. Buckley, N.J., Johnson, R., Zuccato, C., Bithell, A., Cattaneo, E., The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiol. Dis. 39 (2010), 28–39.
6. Butenschön, J., Zimmermann, T., Schmarowski, N., Nitsch, R., Fackelmeier, B., Friedemann, K., Radyushkin, K., Baumgart, J., Lutz, B., Leschik, J., PSA-NCAM positive neural progenitors stably expressing BDNF promote functional recovery in a mouse model of spinal cord injury. Stem Cell Res. Ther., 7, 2016, 11.
7. Chiang, M., Chen, C., Lee, M., Chen, H., Chen, H., Wu, Y., Hung, C., Kang, J., Chang, C., Chang, C., et al. Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma. Hum. Mol. Genet. 19 (2010), 4043–4058.
8. Chiarlone, A., Bellocchio, L., Blazquez, C., Resel, E., Soria-Gomez, E., Cannich, A., Ferrero, J.J., Sagredo, O., Benito, C., Romero, J., et al. A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc. Natl. Acad. Sci. USA 111 (2014), 8257–8262.
9. Connor, B., Sun, Y., von, H.D., Tang, S.K., Jones, K.S., Maucksch, C., AAV-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease. Gene Ther. 23 (2016), 283–295.
10. Danjo, T., Eiraku, M., Muguruma, K., Watanabe, K., Kawada, M., Yanagawa, Y., Rubenstein, J.L., Sasai, Y., Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J. Neurosci. 31 (2011), 1919–1933.
11. Delli, C.A., Onorati, M., Lelos, M.J., Castiglioni, V., Faedo, A., Menon, R., Camnasio, S., Vuono, R., Spaiardi, P., Talpo, F., et al. Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development 140 (2013), 301–312.
12. Ebert, A.D., Barber, A.E., Heins, B.M., Svendsen, C.N., Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. Exp. Neurol. 224 (2010), 155–162.
13. El-Akabawy, G., Rattray, I., Johansson, S.M., Gale, R., Bates, G., Modo, M., Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease. BMC. Neurosci., 13, 2012, 97.
14. Fink, K.D., Rossignol, J., Crane, A.T., Davis, K.K., Bombard, M.C., Bavar, A.M., Clerc, S., Lowrance, S.A., Song, C., Lescaudron, L., et al. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis. Stem Cell Res. Ther., 4, 2013, 130.
15. Foltstein, S.E., Jensen, B., Leigh, R.J., Foltstein, M., The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav. Toxicol. Teratol. 5 (1983), 605–609.
16. Gallina, P., Paganini, M., Lombardini, L., Mascalchi, M., Porfirio, B., Gadda, D., Marini, M., Pinzani, P., Salvianti, F., Crescioli, C., et al. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp. Neurol. 222 (2010), 30–41.
17. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S., et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004), 127–138.
18. Gokce, O., Runne, H., Kuhn, A., Luthi-Carter, R., Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation. PLoS One, 4, 2009, e5292.
19. Ivkovic, S., Ehrlich, M.E., Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J. Neurosci. 19 (1999), 5409–5419.
20. Koller, W.C., Trimble, J., The gait abnormality of Huntington's disease. Neurology 35 (1985), 1450–1454.
21. Labandeira-Garcia, J.L., Wictorin, K., Cunningham, E.T. Jr., Bjorklund, A., Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience 42 (1991), 407–426.
22. Landles, C., Bates, G.P., Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 5 (2004), 958–963.
23. Leschik, J., Eckenstaler, R., Nieweg, K., Lichtenecker, P., Brigadski, T., Gottmann, K., Lessmann, V., Lutz, B., Embryonic stem cells stably expressing BDNF-GFP exhibit a BDNF-release-dependent enhancement of neuronal differentiation. J. Cell Sci. 126 (2013), 5062–5073.
24. Ma, L., Hu, B., Liu, Y., Vermilyea, S.C., Liu, H., Gao, L., Sun, Y., Zhang, X., Zhang, S.C., Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10 (2012), 455–464.
25. McMurray, C.T., Huntington's disease. Expanding horizons for treatment. Lancet, 358(Suppl), 2001, S37.
26. Ortega, J.A., Alcantara, S., BDNF/MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration. Cereb. Cortex 20 (2010), 2132–2144.
27. Plotkin, J.L., Day, M., Peterson, J.D., Xie, Z., Kress, G.J., Rafalovich, I., Kondapalli, J., Gertler, T.S., Flajolet, M., Greengard, P., et al. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease. Neuron 83 (2014), 178–188.
28. Ramaswamy, S., McBride, J.L., Kordower, J.H., Animal models of Huntington's disease. ILAR. J. 48 (2007), 356–373.
29. Rauskolb, S., Zagrebelsky, M., Dreznjak, A., Deogracias, R., Matsumoto, T., Wiese, S., Erne, B., Sendtner, M., Schaeren-Wiemers, N., Korte, M., et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30 (2010), 1739–1749.
30. Sari, Y., Huntington's disease: from mutant huntingtin protein to neurotrophic factor therapy. Int. J. Biomed. Sci. 7 (2011), 89–100.
31. Shin, E., Palmer, M.J., Li, M., Fricker, R.A., GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington's disease. Stem Cell Rev. 8 (2012), 513–531.
32. Snyder, B.R., Chiu, A.M., Prockop, D.J., Chan, A.W., Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease. PLoS One, 5, 2010, e9347.
33. Tattersfield, A.S., Croon, R.J., Liu, Y.W., Kells, A.P., Faull, R.L., Connor, B., Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience 127 (2004), 319–332.
34. Trzaska, K.A., Rameshwar, P., Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol. Biol. 698 (2011), 295–303.
35. Vandeputte, C., Taymans, J.M., Casteels, C., Coun, F., Ni, Y., Van, L.K., Baekelandt, V., Automated quantitative gait analysis in animal models of movement disorders. BMC. Neurosci., 11, 2010, 92.
36. Vilar, M., Mira, H., Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles. Front Neurosci., 10, 2016, 26.
37. Watts, C., Dunnett, S.B., Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. J. Neurosurg. 89 (1998), 267–274.
38. Zuccato, C., Cattaneo, E., Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 5 (2009), 311–322.
39. Zuccato, C., Marullo, M., Conforti, P., MacDonald, M.E., Tartari, M., Cattaneo, E., Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol. 18 (2008), 225–238.